logo

Assessment of the Impact of the COVID-19 Pandemic on People with Rheumatic Diseases in Europe

What was the reason behind REUMAVID?

  • REUMAVID aims to assess the impact of the COVID-19 pandemic and lockdown measures on the disease activity and function, access to healthcare and treatment, support services, wellbeing, mental health, and hopes and fears of people living with rheumatic and musculoskeletal diseases (RMDs).
  • Capturing the Patients’ Perspective in order to address unmet needs on issues that matters to patients during COVID-19 pandemic and lockdown.  
  • Generating evidence-based information to raise awareness on the impact of the pandemic on patients with RMDs.
  • Providing patient organizations data that will allow to advocate for patients’ rights in crisis situations
  • Identifying the fears and hopes of patients during the pandemic

Reumavid in numbers

1
Patients recruited across europe
1
countries
1
Patient Organizations
1
Scientific Conferences

Had their rheumatologist appointment cancelled

58%

Increased smoking

25%

Raised their alcohol consumption

18%

Were unable to continue exercising

46%

Were at risk of anxiety

57%

Were at risk of depression

46%

Our
News

Participating Patient Organizations

REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)

Supported by

© 2021 All Rights Reserved

Centro de preferencias de privacidad

      Necessary

      Advertising

      Analytics

      Other

      This website uses its own and third-party cookies to analyze and improve your browsing experience. By continuing to browse, we understand that you accept their use.    More information
      Privacidad